AzTrials
AzTrials

Peripheral Facial ParalysisMATPFNCT03284125

Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis

An observational study of Peripheral Facial Paralysis, run by University Hospital, Tours at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The facial paralysis is a frequent disease causing important functionals swallowing dysfunctions. The purpose of our study was to evaluate the improvement of the swallowing disorders after surgery by lengthening temporalis myoplasty (LTM) in the facial paralysis. Read more about this study

Who is it for?
Ages 6 years and older
Conditions the study is for
Peripheral Facial Paralysis
What is being tested?
Swallowing disorders evaluation
How many people
13 participants
Where
1 siteFrance
Study dates
2 Sep 2017to 12 Jun 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All patients affected by facial paralysis and treated by lenthening temporalis myoplasty

Who may be able to join

  • Chronic peripheral facial paralysis
  • Freyss score inferior at 15
  • Benefiting of a lengthening temporalis myoplasty

Who cannot join

  • Malformative syndrome
  • Other swallowing trouble
  • Psychiatric trouble
  • Opposed at this study

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service de chirurgie maxillo-faciale, CHRU de TOURS

    Tours, 37044

Other trials in France

About this study

The facial paralysis is a frequent disease causing important functionals swallowing dysfunctions. The purpose of our study was to evaluate the improvement of the swallowing disorders after surgery by lengthening temporalis myoplasty (LTM) in the facial paralysis.

This prospective study has realised on the following of patients affected by facial paralysis treated by LTM. Self-administered questionnaires and clinics tests had realized to analyze three components oh the oral phase of the swallowing ( drooling, mastication and handicap). The evaluations was realized before the surgery and at 3 and 6 months after .

Being tested
Swallowing disorders evaluation
Medical subject headings
Facial Paralysis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Swallowing disorders evaluationOther

    Self-administered questionnaires and non-invasive clinics tests

Study groups in NCT03284125
Study groupRoleWhat they receive
Facial paralysisPatients affected by facial paralysis treated by LTM The aim is to evaluate the improvement of the swallowing disorders after surgery.
Receives: Other: Swallowing disorders evaluation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline lips pressure at 6 months

    Patients must contracted their lips of the paretic side in a manometer to evaluate the pressure of the lips before surgery and at 3 and 6 months after

    Measured: Baseline, 3 and 6 months

Secondary outcomes (3)
  1. Drooling Severity and Frequency Scale (DSFS)

    The Drooling Score equals the sum of the Severity and Frequency sub-scores. the severity sub scores contains five items ( 1= never, 2= mild drooling, 3= moderate drool, 4= severe drool, 5= profuse drool) The frequency sub score contains four items ( 1= no drooling, 2= occasionally, 3=frequently, 4= constant drooling)

    Measured: Baseline, 3 and 6 months

  2. Visual scale of food residue

    Patients must eat a melba toast on paretic side and after we evaluate the food residue before surgery and at 3 and 6 months after

    Measured: Baseline, 3 and 6 months

  3. Dysphagia handicap index (DHI)

    This self-administered questionnaire allows to evaluate 3 types of handicap (physical, functional and social) It contains 30 questions and the maximum score is 120 (0= never, 1= almost never, 2= occasionally, 3= almost always, 4= always)

    Measured: Baseline, 3 and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2017
  2. Study start2 Sep 2017
  3. Primary completion12 Jun 2018
  4. Study completion12 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03284125
Sponsor's protocol ID
RIPH3-RNI17/MATPF
Other IDs
2017-A01577-46, 2017-39
Acronym
MATPF
Status last verified
Apr 2021
First submitted
6 Sep 2017
Last updated
28 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Peripheral Facial Paralysis, run by University Hospital, Tours at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline lips pressure at 6 months (time frame: Baseline, 3 and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in